39590-81-3Relevant articles and documents
Cyclopropyloxetanes. Reactions of 5-Oxaspirohexane with Hydrogen Halides
Donnelly, John A.,Keegan, John R.
, p. 209 - 212 (1982)
The title cyclopropyloxetane reacted with aqueous hydrogen chloride, bromide, and iodide to give mixtures of the corresponding 1-(halogenomethyl)-1-(hydroxymethyl)cyclopropane and 1-halogeno-1-(hydroxymethyl)cyclobutane.Keywords: Bicyclobutonium ion; Cyclopropyl carbinyl cation; Molecular rearrangement; Oxetane.
Preparing method for 1,1-cyclopropyl dimethyl carbinol
-
Paragraph 0040; 0045; 0048; 0051; 0054, (2017/08/28)
The invention belongs to the technical field of drug synthesis and relates to a preparing method for 1,1-cyclopropyl dimethyl carbinol. Specifically, the preparing method for the 1,1-cyclopropyl dimethyl carbinol includes the following steps that firstly, under the participation of a catalyst A, a solvent A and an acid-binding agent, diethyl malonate and 1,2-dichloroethane are used for preparing 1,1-cyclopropyl dioctyl phthalate diethyl ester; and secondly, under the participation of a solvent B and a catalyst B, a reducing agent is used for reducing the 1,1-cyclopropyl dioctyl phthalate diethyl ester, and the target product 1,1-cyclopropyl dimethyl carbinol is obtained. Raw materials adopted in the preparing method are cheap, easy to obtain and free of toxins, the activity of the catalysts are high, the solvents can be recycled, and the cost is obviously reduced; and reaction conditions are moderate, the products are easy to separate, the three industrial wastes are little, and the environment-friendly chemical requirement is met. In addition, according to the preparing method, the yield of the target product can be obviously increased, and the total recovery can reach 88% through the two steps.
Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors
Zhao, Zhiqiang,Pissarnitski, Dmitri A.,Josien, Hubert B.,Bara, Thomas A.,Clader, John W.,Li, Hongmei,McBriar, Mark D.,Rajagopalan, Murali,Xu, Ruo,Terracina, Giuseppe,Hyde, Lynn,Song, Lixin,Zhang, Lili,Parker, Eric M.,Osterman, Rebecca,Buevich, Alexei V.
, p. 36 - 48 (2016/08/25)
The design, synthesis, SAR, and biological profile of a substituted 4-morpholine sulfonamide series of γ-secretase inhibitors (GSIs) were described. In several cases, the resulting series of GSIs reduced CYP liabilities and improved γ-secretase inhibition activity compared to our previous research series. Selected compounds demonstrated significant reduction of amyloid-β (Aβ) after acute oral dosing in a transgenic animal model of Alzheimer's disease (AD).